Purchase, Susan E.
Seddon, James A.
Zimri, Klassina
Klaas, Anele
Duong, Trinh
Martinson, Neil A.
Patel, Faeezah
Staples, Suzanne
Viljoen, Lario
Schaaf, H. Simon
Hesseling, Anneke C.
Funding for this research was provided by:
UNITAID (2019-36-SUN-MDR)
Article History
Received: 18 August 2025
Accepted: 18 December 2025
First Online: 22 January 2026
Declarations
:
: The main TB-CHAMP trial was approved by the Health Research Ethics Committee of Stellenbosch University (M16/02/009) and the University of the Witwatersrand (160409), the South African Health Products Regulatory Agency (20160128), and the South African Department of Health (DOH-27–0117-5309) and was registered in the ISRCTN registry (ISRCTN92634082). Informed consent was provided by all participants’ parents or legal guardians. Data were stored using unique anonymized participant identifiers.
: Not applicable.
: The authors declare that they have no competing interests.